AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 26-50/70
ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS
Authors: ZINZANI PL BENDANDI M MARTELLI M FALINI B SABATTINI E AMADORI S GHERLINZONI F MARTELLI MF MANDELLI F TURA S PILERI SA
Citation: Pl. Zinzani et al., ANAPLASTIC LARGE-CELL LYMPHOMA - CLINICAL AND PROGNOSTIC EVALUATION OF 90 ADULT PATIENTS, Journal of clinical oncology, 14(3), 1996, pp. 955-962
INFLAMMATORY FIBROSARCOMA - ANOTHER IMITATOR OF HODGKINS-DISEASE - CRITICAL COMMENTARY
Authors: PILERI SA SABATTINI E FALINI B
Citation: Sa. Pileri et al., INFLAMMATORY FIBROSARCOMA - ANOTHER IMITATOR OF HODGKINS-DISEASE - CRITICAL COMMENTARY, Pathology research and practice, 192(5), 1996, pp. 481-482
SHC PROTEINS ARE LOCALIZED ON ENDOPLASMIC-RETICULUM MEMBRANES AND AREREDISTRIBUTED AFTER TYROSINE KINASE RECEPTOR ACTIVATION
Authors: LOTTI LV LANFRANCONE L MIGLIACCIO E ZOMPETTA C PELICCI G SALCINI AE FALINI B PELICCI PG TORRISI MR
Citation: Lv. Lotti et al., SHC PROTEINS ARE LOCALIZED ON ENDOPLASMIC-RETICULUM MEMBRANES AND AREREDISTRIBUTED AFTER TYROSINE KINASE RECEPTOR ACTIVATION, Molecular and cellular biology, 16(5), 1996, pp. 1946-1954
14Q-CELL-RICH B-CELL LYMPHOMA( CHROMOSOME MARKER IN A T)
Authors: LASTARZA R AVENTIN A FALZETTI D STUL M MARTELLI MF FALINI B MECUCCI C
Citation: R. Lastarza et al., 14Q-CELL-RICH B-CELL LYMPHOMA( CHROMOSOME MARKER IN A T), Journal of pathology, 178(2), 1996, pp. 227-231
INDUCTION OF APOPTOSIS BY RIBOSOME-INACTIVATING PROTEINS AND RELATED IMMUNOTOXINS
Authors: BOLOGNESI A TAZZARI PL OLIVIERI F POLITO L FALINI B STIRPE F
Citation: A. Bolognesi et al., INDUCTION OF APOPTOSIS BY RIBOSOME-INACTIVATING PROTEINS AND RELATED IMMUNOTOXINS, International journal of cancer, 68(3), 1996, pp. 349-355
ANTI-CD30 (BER-H2) IMMUNOTOXINS CONTAINING THE TYPE-1 RIBOSOME-INACTIVATING PROTEINS MOMORDIN AND PAP-S (POKEWEED ANTIVIRAL PROTEIN FROM SEEDS) DISPLAY POWERFUL ANTITUMOR-ACTIVITY AGAINST CD30(-CELLS IN-VITRO AND IN SCID MICE() TUMOR)
Authors: TERENZI A BOLOGNESI A PASQUALUCCI L FLENGHI L PILERI S STEIN H KADIN M BIGERNA B POLITO L TAZZARI PL MARTELLI MF STIRPE F FALINI B
Citation: A. Terenzi et al., ANTI-CD30 (BER-H2) IMMUNOTOXINS CONTAINING THE TYPE-1 RIBOSOME-INACTIVATING PROTEINS MOMORDIN AND PAP-S (POKEWEED ANTIVIRAL PROTEIN FROM SEEDS) DISPLAY POWERFUL ANTITUMOR-ACTIVITY AGAINST CD30(-CELLS IN-VITRO AND IN SCID MICE() TUMOR), British Journal of Haematology, 92(4), 1996, pp. 872-879
THE BCL-6 GENE HARBORS FREQUENT MUTATIONS OF ITS REGULATORY SEQUENCESIN AIDS-RELATED NON-HODGKIN LYMPHOMAS AND ITS PROTEIN EXPRESSION IS INVERSELY CORRELATED WITH EXPRESSION OF EBV-ENCODED
Authors: GAIDANO G SAGLIO G GLOGHINI A PASTORE C CAPELLO D MIGLIAZZA A TIRELLI U FALINI B DALLAFAVERA R CARBONE A
Citation: G. Gaidano et al., THE BCL-6 GENE HARBORS FREQUENT MUTATIONS OF ITS REGULATORY SEQUENCESIN AIDS-RELATED NON-HODGKIN LYMPHOMAS AND ITS PROTEIN EXPRESSION IS INVERSELY CORRELATED WITH EXPRESSION OF EBV-ENCODED, Blood, 88(10), 1996, pp. 2532-2532
DISTINCTIVE EXPRESSION PATTERN OF THE BCL-6 PROTEIN IN NODULAR LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE
Authors: FALINI B BIGERNA B PASQUALUCCI L FIZZOTTI M MARTELLI MF PILERI S PINTO A CARBONE A VENTURI S PACINI R CATTORETTI G PESCARMONA E LOCOCO F PELICCI PG ANAGNASTOPOULOS I DALLAFAVERA R FLENGHI L
Citation: B. Falini et al., DISTINCTIVE EXPRESSION PATTERN OF THE BCL-6 PROTEIN IN NODULAR LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE, Blood, 87(2), 1996, pp. 465-471
HETEROGENEOUS NUCLEAR EXPRESSION OF THE PROMYELOCYTIC LEUKEMIA (PML) PROTEIN IN NORMAL AND NEOPLASTIC HUMAN TISSUES
Authors: GAMBACORTA M FLENGHI L FAGIOLI M PILERI S LEONCINI L BIGERNA B PACINI R TANCI LN PASQUALUCCI L ASCANI S MENCARELLI A LISO A PELICCI PG FALINI B
Citation: M. Gambacorta et al., HETEROGENEOUS NUCLEAR EXPRESSION OF THE PROMYELOCYTIC LEUKEMIA (PML) PROTEIN IN NORMAL AND NEOPLASTIC HUMAN TISSUES, The American journal of pathology, 149(6), 1996, pp. 2023-2035
MONOCLONAL-ANTIBODIES PG-B6A AND PG-B6P RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION
Authors: FLENGHI L BIGERNA B FIZZOTTI M VENTURI S PASQUALUCCI L PILERI S YE BH GAMBACORTA M PACINI R BARONI CD PESCARMONA E ANAGNOSTOPOULOS I STEIN H ASDRUBALI G MARTELLI MF PELICCI PG DALLAFAVERA R FALINI B
Citation: L. Flenghi et al., MONOCLONAL-ANTIBODIES PG-B6A AND PG-B6P RECOGNIZE, RESPECTIVELY, A HIGHLY CONSERVED AND A FORMOL-RESISTANT EPITOPE ON THE HUMAN BCL-6 PROTEIN AMINO-TERMINAL REGION, The American journal of pathology, 148(5), 1996, pp. 1543-1555
MOLECULAR FINDINGS AND CLASSIFICATION OF MALIGNANT-LYMPHOMAS
Authors: PILERI SA CECCARELLI C SABATTINI E SANTINI D LEONE O DAMIANI S LEONCINI L FALINI B
Citation: Sa. Pileri et al., MOLECULAR FINDINGS AND CLASSIFICATION OF MALIGNANT-LYMPHOMAS, Acta haematologica, 95(3-4), 1996, pp. 181-187
LOCAL EXPANSION OF ALLERGEN-SPECIFIC CD30(-TYPE GAMMA-DELTA T-CELLS IN BRONCHIAL-ASTHMA()TH2)
Authors: SPINOZZI F AGEA E BISTONI O FORENZA N MONACO A FALINI B BASSOTTI G DEBENEDICTIS F GRIGNANI F BERTOTTO A
Citation: F. Spinozzi et al., LOCAL EXPANSION OF ALLERGEN-SPECIFIC CD30(-TYPE GAMMA-DELTA T-CELLS IN BRONCHIAL-ASTHMA()TH2), Molecular medicine, 1(7), 1995, pp. 821-826
BONE-MARROW FINDINGS FURTHER SUPPORT THE HYPOTHESIS THAT ESSENTIAL MIXED CRYOGLOBULINEMIA TYPE-II IS CHARACTERIZED BY A MONOCLONAL B-CELL PROLIFERATION
Authors: MONTEVERDE A SABATTINI E POGGI S BALLARE M BERTONCELLI MC DEVIVO A BRISKOMATIS A RONCADOR G FALINI B PILERI SA
Citation: A. Monteverde et al., BONE-MARROW FINDINGS FURTHER SUPPORT THE HYPOTHESIS THAT ESSENTIAL MIXED CRYOGLOBULINEMIA TYPE-II IS CHARACTERIZED BY A MONOCLONAL B-CELL PROLIFERATION, Leukemia & lymphoma, 20(1-2), 1995, pp. 119-124
ANAPLASTIC LARGE-CELL LYMPHOMA - UPDATE OF FINDINGS
Authors: PILERI SA PICCALUGA A POGGI S SABATTINI E PICCALUGA PP DEVIVO A FALINI B STEIN H
Citation: Sa. Pileri et al., ANAPLASTIC LARGE-CELL LYMPHOMA - UPDATE OF FINDINGS, Leukemia & lymphoma, 18(1-2), 1995, pp. 17-25
MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS
Authors: MAZZA P ZINZANI PL MARTELLI M FIACCHINI M BOCCHIA M PILERI S FALINI B MARTELLI MF AMADORI S PAPA G CANTONETTI M LUCARELLI G MORETTI L CALABRESI F RUGGERI E GHERLINZONI F BENDANDI M GUGLIELMI C BURGIO V DAMMACCO F LAUTA VM LIBERATI AM MANDELLI F TURA S
Citation: P. Mazza et al., MACOP-B VS F-MACHOP REGIMEN IN THE TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS, Leukemia & lymphoma, 16(5-6), 1995, pp. 457-463
IS HODGKINS-DISEASE A UNIQUE ENTITY
Authors: PILERI SA POGGI S SABATTINI E DEVIVO A FALINI B STEIN H
Citation: Sa. Pileri et al., IS HODGKINS-DISEASE A UNIQUE ENTITY, Leukemia & lymphoma, 15, 1995, pp. 3-6
THE ACUTE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PML GENE IS INDUCED BY INTERFERON
Authors: LAVAU C MARCHIO A FAGIOLI M JANSEN J FALINI B LEBON P GROSVELD F PANDOLFI PP PELICCI PG DEJEAN A
Citation: C. Lavau et al., THE ACUTE PROMYELOCYTIC LEUKEMIA-ASSOCIATED PML GENE IS INDUCED BY INTERFERON, Oncogene, 11(5), 1995, pp. 871-878
IMMUNOTOXIN THERAPY OF HEMATOLOGICAL MALIGNANCIES
Authors: PASQUALUCCI L FLENGHI L TERENZI A BOLOGNESI A STIRPE F BIGERNA B FALINI B
Citation: L. Pasqualucci et al., IMMUNOTOXIN THERAPY OF HEMATOLOGICAL MALIGNANCIES, Haematologica, 80(6), 1995, pp. 546-554
HIGH-LEVELS OF THE SOLUBLE FORM OF CD30 MOLECULE IN RHEUMATOID-ARTHRITIS (RA) ARE EXPRESSION OF CD30(-CELL INVOLVEMENT IN THE INFLAMED JOINTS() T)
Authors: GERLI R MUSCAT C BISTONI O FALINI B TOMASSINI C AGEA E TOGNELLINI R BIAGINI P BERTOTTO A
Citation: R. Gerli et al., HIGH-LEVELS OF THE SOLUBLE FORM OF CD30 MOLECULE IN RHEUMATOID-ARTHRITIS (RA) ARE EXPRESSION OF CD30(-CELL INVOLVEMENT IN THE INFLAMED JOINTS() T), Clinical and experimental immunology, 102(3), 1995, pp. 547-550
MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS
Authors: FALINI B VENTURI S MARTELLI M SANTUCCI A PILERI S PESCARMONA E GIOVANNINI M MAZZA P MARTELLI MF PASQUALUCCI L BALLATORI E GUGLIELMI C AMADORI S POGGI S SABATTINI E GHERLINZONI F ZINZANI PL BARONI CD MANDELLI F TURA S
Citation: B. Falini et al., MEDIASTINAL LARGE B-CELL LYMPHOMA - CLINICAL AND IMMUNOHISTOLOGICAL FINDINGS IN 18 PATIENTS TREATED WITH DIFFERENT 3RD-GENERATION REGIMENS, British Journal of Haematology, 89(4), 1995, pp. 780-789
BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS
Authors: CATTORETTI G CHANG CC CECHOVA K ZHANG JD YE BH FALINI B LOUIE DC OFFIT K CHAGANTI RSK DALLAFAVERA R
Citation: G. Cattoretti et al., BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS, Blood, 86(1), 1995, pp. 45-53
ANTITUMOR-ACTIVITY OF ANTI-CD30 IMMUNOTOXIN (BER-H2 SAPORIN) IN-VITROAND IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE MICE XENOGRAFTED WITHHUMAN CD30(-CELL LYMPHOMA() ANAPLASTIC LARGE)
Authors: PASQUALUCCI L WASIK M TEICHER BA FLENGHI L BOLOGNESI A STIRPE F POLITO L FALINI B KADIN ME
Citation: L. Pasqualucci et al., ANTITUMOR-ACTIVITY OF ANTI-CD30 IMMUNOTOXIN (BER-H2 SAPORIN) IN-VITROAND IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE MICE XENOGRAFTED WITHHUMAN CD30(-CELL LYMPHOMA() ANAPLASTIC LARGE), Blood, 85(8), 1995, pp. 2139-2146
CHARACTERIZATION OF A NEW MONOCLONAL-ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE-PRODUCT - IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL-CELLS, AND EPITHELIA
Authors: FLENGHI L FAGIOLI M TOMASSONI L PILERI S GAMBACORTA M PACINI R GRIGNANI F CASINI T FERRUCCI PF MARTELLI MF PELICCI PG FALINI B
Citation: L. Flenghi et al., CHARACTERIZATION OF A NEW MONOCLONAL-ANTIBODY (PG-M3) DIRECTED AGAINST THE AMINOTERMINAL PORTION OF THE PML GENE-PRODUCT - IMMUNOCYTOCHEMICAL EVIDENCE FOR HIGH EXPRESSION OF PML PROTEINS ON ACTIVATED MACROPHAGES, ENDOTHELIAL-CELLS, AND EPITHELIA, Blood, 85(7), 1995, pp. 1871-1880
LYMPHOMA CLASSIFICATION PROPOSAL - CLARIFICATION
Authors: HARRIS NL JAFFE ES STEIN H BANKS PM CHAN JKC CLEARY ML DELSOL G DEWOLFPEETERS C FALINI B GATTER KC GROGAN TM ISAACSON PG KNOWLES DM MASON DY MULLERHERMELINK HK PILERI SA PIRIS MA RALFKIAER E WARNKE RA
Citation: Nl. Harris et al., LYMPHOMA CLASSIFICATION PROPOSAL - CLARIFICATION, Blood, 85(3), 1995, pp. 857-860
CD30 (KI-1) MOLECULE - A NEW CYTOKINE RECEPTOR OF THE TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY AS A TOOL FOR DIAGNOSIS AND IMMUNOTHERAPY
Authors: FALINI B PILERI S PIZZOLO G DURKOP H FLENGHI L STIRPE F MARTELLI MF STEIN H
Citation: B. Falini et al., CD30 (KI-1) MOLECULE - A NEW CYTOKINE RECEPTOR OF THE TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY AS A TOOL FOR DIAGNOSIS AND IMMUNOTHERAPY, Blood, 85(1), 1995, pp. 1-14
Risultati: 1-25 | 26-50 | 51-70